Fujifilm Diosynth celebrates expansion in Denmark

By The Science Advisory Board staff writers

March 4, 2021 -- Contract development and manufacturing organization (CDMO) Fujifilm Diosynth Biotechnologies held a ceremony on March 3 to celebrate the large-scale expansion of cell culture capacity at its production facility in Hillerød, Denmark.

The expansion project includes the addition of six 20,000-L bioreactors, which represents a doubling of the facility's bulk drug substance production capacity and the installation of fill/finish capability to support production of approximately 35 million units per year, Fujifilm Diosynth said in a statement.

Turning of the soil at Fujifilm Diosynth Biotechnologies in Denmark signals the start of expansion project. Image courtesy of Fujiflim Diosynth.

The revamp was made possible by a capital investment of 100 billion yen ($928 million U.S.) from parent company Fujifilm. Fujifilm Diosynth said that it is adding 300 staff in Denmark by the end of 2023 to support new activities.

Fujifilm secures funding, signs lease for new research/manufacturing center
Fujifilm Diosynth Biotechnologies has announced $76 million in financing for the Center for Advanced Biological Innovation and Manufacturing and...
Fujifilm invests $2B on cell culture manufacturing
Fujifilm plans to invest more than $2 billion to build a large-scale cell culture manufacturing site for biopharmaceuticals in the U.S.
Fujifilm Diosynth breaks ground on biologics facility
Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization for biologics, viral vaccines, and gene therapies, held a virtual...
Novavax, Fujifilm begin large-scale manufacturing of COVID-19 vaccine
Novavax and Fujifilm Diosynth have signed an agreement covering the bulk manufacture of Novavax's COVID-19 vaccine candidate, NVX-CoV2373, at Fujifilm's...
Allterum, FujiFilm begin development, scale-up of monoclonal antibodies for leukemia
Allterum Therapeutics has received a $2.9 million product development grant from the Cancer Research and Prevention Institute of Texas to support...

Copyright © 2021 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter